Cui Jiang

Shenyang, 110042, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Engineering smart polymeric lipid nanoparticles for breast cancer: AI-guided formulation design, biological barriers, and translational constraints.

Engineering smart polymeric lipid nanoparticles for breast cancer: AI-guided formulation design, biological barriers, and translational constraints.

Journal: Journal of nanobiotechnology

Published: April 10, 2026

BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1.

BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1.

Journal: Breast cancer research : BCR

Published: August 26, 2025

First-principles prediction of intrinsic ferrovalley properties in Janus rare-earth PrXY (X ≠ Y = Cl, Br, I) monolayers.

First-principles prediction of intrinsic ferrovalley properties in Janus rare-earth PrXY (X ≠ Y = Cl, Br, I) monolayers.

Journal: Physical chemistry chemical physics : PCCP

Published: January 24, 2025

Quantum Anomalous Layer Hall Effect in Realistic van der Waals Heterobilayers.

Quantum Anomalous Layer Hall Effect in Realistic van der Waals Heterobilayers.

Journal: Nano letters

Published: December 17, 2024

Pyrotinib and Nab-Paclitaxel in HER2-Positive Breast Cancer (PANHER Trial): A Prospective, Single-Arm, Phase II Trial.

Pyrotinib and Nab-Paclitaxel in HER2-Positive Breast Cancer (PANHER Trial): A Prospective, Single-Arm, Phase II Trial.

Journal: Cancer science

Published: November 21, 2024

Real-world efficacy and safety of inetetamab-based therapy in HER2-positive metastatic breast cancer patients with prior exposure to trastuzumab.

Real-world efficacy and safety of inetetamab-based therapy in HER2-positive metastatic breast cancer patients with prior exposure to trastuzumab.

Journal: Frontiers in oncology

Published: September 14, 2024

Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment.

Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment.

Journal: Oncogene

Published: April 12, 2023

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.

Journal: Frontiers in oncology

Published: December 24, 2021

Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice.

Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice.

Journal: Cell reports

Published: November 17, 2021

The NAD-dependent deacetylase SIRT2 regulates T cell differentiation involved in tumor immune response.

The NAD-dependent deacetylase SIRT2 regulates T cell differentiation involved in tumor immune response.

Journal: International journal of biological sciences

Published: June 20, 2020

Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial.

Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial.

Journal: Frontiers in oncology

Published: April 21, 2020

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer.

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer.

Journal: Cancer cell international

Published: June 30, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026